Evidence map›Paper›PMID 34374936›Full record

ReviewProtein & cell2022

The mini player with diverse functions: extracellular vesicles in cell biology, disease, and therapeutics.

Abhimanyu Thakur, Xiaoshan Ke, Ya-Wen Chen, Pedram Motallebnejad, Kui Zhang, Qizhou Lian, Huanhuan Joyce Chen

Open access · diamondAbstract readReview
In one paragraph

Review in Protein & cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 132 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Tumor-derived extracellular vesicles: Bridging communication and next-generation theranostics.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Abhimanyu ThakurThe Pritzker School of Molecular Engineering, The University of Chicago, Chicago, Illinois, USA.ORCID 0000-0002-0846-0998
Xiaoshan KeThe Pritzker School of Molecular Engineering, The University of Chicago, Chicago, Illinois, USA.ORCID 0000-0003-2181-4428
Ya-Wen ChenDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Keck School of Medicine, Hastings Center for Pulmonary Research, University of Southern California, Los Angeles, CA, 90089, USA.ORCID 0000-0003-2382-8444
Pedram MotallebnejadThe Pritzker School of Molecular Engineering, The University of Chicago, Chicago, Illinois, USA.ORCID 0000-0001-7999-2310
Kui ZhangThe Pritzker School of Molecular Engineering, The University of Chicago, Chicago, Illinois, USA.ORCID 0000-0001-9618-610X
Qizhou LianDepartment of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong. qzlian@hku.hk.ORCID 0000-0001-8189-7160
Huanhuan Joyce ChenThe Pritzker School of Molecular Engineering, The University of Chicago, Chicago, Illinois, USA. joycechen@uchicago.edu.ORCID 0000-0002-1446-7184
University of Chicago · USUniversity of Hong Kong · HKUniversity of Southern California · US

Funding

Investigation of sub-lineages in pulmonary neuroendocrine cells and identification of the cells of origin of small cell lung cancerR00CA226353 · NCI · UNIVERSITY OF CHICAGO · PI CHEN, JOYCE HUANHUAN · 2020 to 2022
$747k
NCI NIH HHS R00 CA226353
6 · The paper itself

Abstract

Extracellular vesicles (EVs) are tiny biological nanovesicles ranging from approximately 30-1000 nm in diameter that are released into the extracellular matrix of most cell types and in biofluids. The classification of EVs includes exosomes, microvesicles, and apoptotic bodies, dependent on various factors such as size, markers, and biogenesis pathways. The transition of EV relevance from that of being assumed as a trash bag to be a key player in critical physiological and pathological conditions has been revolutionary in many ways. EVs have been recently revealed to play a crucial role in stem cell biology and cancer progression via intercellular communication, contributing to organ development and the progression of cancer. This review focuses on the significant research progress made so far in the role of the crosstalk between EVs and stem cells and their niche, and cellular communication among different germ layers in developmental biology. In addition, it discusses the role of EVs in cancer progression and their application as therapeutic agents or drug delivery vehicles. All such discoveries have been facilitated by tremendous technological advancements in EV-associated research, especially the microfluidics systems. Their pros and cons in the context of characterization of EVs are also extensively discussed in this review. This review also deliberates the role of EVs in normal cell processes and disease conditions, and their application as a diagnostic and therapeutic tool. Finally, we propose future perspectives for EV-related research in stem cell and cancer biology.

Indexed as

Cell-Derived MicroparticlesExosomesExtracellular VesiclesNeoplasmsBiomarkersHumansBiomarkerscancerexosomal communicationexosomal therapeuticsexosomesextracellular vesiclesstem cells

Identifiers

PMID34374936
PMCPMC9233731
OpenAlexW3189667439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.